Risk factors for ischemic stroke. The role of vitamin D
https://doi.org/10.52420/2071-5943-2021-20-4-93-98
Abstract
Introduction. The prevalence of cerebral vascular diseases is steadily increasing worldwide. Cerebral stroke represents the most serious of them, being one of the leading causes of mortality and disability of the population. Reduction of morbidity and mortality from stroke can be achieved by improving preventive measures aimed at the correction of risk factors. The review presents domestic and foreign literature data on the risk factors of ischemic stroke and the system of primary prevention of acute ischemic brain lesions.
Materials and methods. Data from eLibrary, MedLine, Scopus, Springerlink, and the scientific electronic library «Cyberleninka» were analyzed.
Results and Discussion. The authors give an overview of pathological conditions that can lead to the development of cerebral vascular accident. Methods of primary prevention of ischemic stroke are considered in accordance with the European guidelines on stroke management. Current views on the correction of modifiable risk factors (arterial hypertension, diabetes mellitus, hyperlipidemia, heart and vascular pathology, etc.) are presented. Recommendations on lifestyle and body weight reduction are given. In addition to the well-known information, the authors present the data of new studies on the role of vitamin D in the ischemic cascade and consider the possible pathogenetic mechanisms of this effect. The review also provides information on the association of vitamin D deficiency with other pathological conditions that are the causes of ischemic stroke and the effect of vitamin D on the volume of ischemic lesions, the severity of the outcome and the risks of repeated vascular accidents.
Conclusion. The study of risk factors for ischemic stroke and the development of primary prevention methods is one of the priority areas of modern neurology, since it will improve the system of care for patients with cerebrovascular disease.
About the Authors
O. A. Kicherova
Tyumen State Medical University
Russian Federation
Russian Federation
Oksana A. Kicherova — Doctor of Science (Medicine), Associate Professor
Tyumen
L. I. Rejhert
Tyumen State Medical University
Russian Federation
Russian Federation
Ljudmila I. Rejhert — Doctor of Science (Medicine)
Tyumen
M. A. Ahmetianov
Tyumen State Medical University
Russian Federation
Russian Federation
Marsel A. Ahmetianov — Resident
Tyumen
References
1. Банк готовых документов: Демографический ежегодник России – 2013 год. – Сайт Федеральной службы государственной статистики.
2. Perk, J. European guidelines on cardiovascular disease prevention in clinical practice (version 2012) / J. Perk, G. De Backer, H. Gohlke [et al] / European heart journal. – 2012. – Vol. 33, № 13. – P. 1635-701.
3. Рейхерт Л. И., Кичерова О. А., Прилепская О. А. Острые и хронические проблемы цереброваскулярной патологии. Тюмень, 2015.
4. Update to the AHA/ASA Recommendations for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack / Adams R. J., Albers G., Alberts M. J. et al. // Stroke. – 2008; 39: 1647–52.
5. Клинические рекомендации по ведению больных с ишемическим инсультом и транзиторными ишемическими атаками (утверждены профильной комиссией по неврологии Экспертного Совета МЗ РФ, председатель– академик РАН Е.И. Гусев), Москва, 2020.
6. Incidence and prognosis of transient neurological attacks / M. J. Bos, M. J. van Rijn, J. C. Witteman [et al] // JAMA. – 2007. – Vol. 298, № 24. – Р. 2877 – 2885.
7. Неврология: национальное руководство. – Москва, 2018. Т. 1 (2-е издание переработанное и дополненное.
8. Диагностика и лечение артериальной гипертензии / Национальные клинические рекомендации / под ред. Р. Г. Оганова. – М. : Изд-во «Силицея – Полиграф», 2010. – с. 464 – 500.
9. Андреева, О. С Гипертонические кризы у пациентов с хронической цереброваскулярной патологией (по данным эпидемиологического исследования) // О. С. Андреева, Ю. Я. Варакин, Г. В. Горностаева [и др.] // Сборник статей и тезисов II Национального конгресса «Кардионеврология» / под ред. З. А. Суслиной [и др.]. – М., 2012. – с. 58 – 60.
10. Алифирова В. М., Антухова О. М. Результаты регистра инсульта в популяции закрытого территориального образования // Материалы IX Всероссийского съезда неврологов. – Ярославль. – 2006. – с. 361.
11. Direct stenting strategy is assotiated with improved outcomes in patients with improved outcomes in patients with totally occluded culprit arteries undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction / Bessonov I., Zyryanov I., Sapozhnikov S., Kuznetsov V. // Journal of the American College of Cardiology. – 2017. Т70. № S18.С.В1
12. Влияние плановых чрескожных коронарных вмешательств на показатели смертности населения Тюменской области / Кузнецов В. А., Ярославская Е. И., Пушкарев Г. С. и др. // Российский кардиологический журнал. – 2015. – Т.20, № 6. – С. 25-29
13. Доян Ю. И., Кичерова О. А., Рейхерт Л. И. Генетические детерминанты предрасположенности к развитию ишемического инсульта. Современный взгляд на проблему. Медицинская наука и образование Урала. 2017. Т.18. № 1(89). С. 152-155.
14. Широков. Е. А. Первичная профилактика ишемического инсульта: антитромботическая терапия // Лечащий врач. – 2015. – № 5. – С.25.
15. Атеротромботическая терапия у больных со стабильными проявлениями атеротромбоза // Национальные клинические рекомендации / под ред. Р. Г. Оганова. – М. : Изд – во «Силицея – Полиграф», 2010. – с. 164 – 188.
16. Classification of Subtype of aqute ischemic stroke: definition of use in a multicenter clinical Trial: TOAST: Trial of Org 10172 in Acute Stroke Treatment / Adams H. P., Bendixen B. H., Kapelle L. J. et al. // Stroke, 1993, № 24. – P. 35-41.
17. Инсульт : Руководство для врачей / под ред. Л. В. Стаховской, С. В. Котова. – Москва, 2018. – 488 с.
18. Primary prevention of cardiovascular disease with a Mediterranean diet / Estruch R., Ros E., Salas-Salvado J. et al. // N Engl J Med. – 2013. – DOI: 10.1056/NEJMoa200303. Controlled-Trials.com number, ISRCTN35739639.
19. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2018; 49 (3): 46-99. https://doi.org/10.1161/str.0000000000000163.
20. Cannell J. J.; Grant W. B.; Holick M. F. Vitamin D and inflammation. Dermatoendocrinology 2014, 6, e983401.
21. Vitamin D decreases NFkappaB activity by increasing IkappaBalpha levels / Cohen-Lahav M., Shany S., Tobvin D. et al. // Nephrol. Dial. Transplant. – 2006, 21, 889–897.
22. Vitamin D modulates prostaglandin E2 synthesis and degradation in human lung fibroblasts / Liu X., Nelson A., Wang X. et al. // Am. J. Respir. Cell Mol. Biol. – 2014. – 50. – Р. 40–50.
23. Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4 + Foxp3 + regulatory T cells by 1,25-dihydroxyvitamin D3 / Penna G., Roncari A., Amuchastegui S. et al. // Blood 2005, 106, 3490–3497.
24. Effect of Vitamin D Deficiency and Replacement on Endothelial Function in Asymptomatic Subjects / Tarcin O., Yavuz D. G., Ozben B. et al. // J. Clin. Endocrinol. Metab. 2009, 94, 4023–4030.
25. Thouvenot E., Camu W. Vitamine D et neurologie. Presse Med 2013;42(10):1398–404.
26. Vitamin D status, hypertension and ischemic stroke: a clinical perspective / Majumdar V., Prabhakar P., Kulkarni G. B. Christopher R. // J Hum Hypertens. – 2015; 1–6.
27. Brøndum-Jacobsen P., Nordestgaard B. G., Schnohr P., Benn M. 25-hydroxyvitamin D and symptomatic ischemic stroke: an original study and meta-analysis. Ann Neurol 2013;73(1):38–47. http://dx.doi.org/10.1002/ana.23738 [Epub 2012 Dec 7].
28. Serum 25-hydroxyvitamin D predicts severity and prognosis in stroke patients / Daubail B., Jacquin A., Guilland J.-C. et al. // Eur. J. Neurol. – 2013, – 20, – 57–61.
29. Vitamin D deficiency and incident stroke risk in community-living black and white adults / Judd S. E.. Morgan, C. J., Panwar B. et al. // Int. J. Stroke. – 2016, 11, 93–102.
30. Relationship between dietary vitamin D and deaths from stroke and coronary Heart disease: the Japan Collaborative Cohort Study / Sheerah H. A., Eshak E. S., Cui R. et al. // Stroke. (2018) 49:454–57.doi: 10.1161/STROKEAHA.117.019417.
31. Vitamin D in childhood and adolescence: an expert position statement / Saggese G., Vierucci F., Boot A. M. et al. // Eur J Pediatr. (2015) 174:565–76. doi: 10.1007/s00431-015-2524-6.
32. Vitamin D Status and the Risk of Recurrent Stroke and Mortality in Ischemic Stroke Patients: Data from a 24-Month Follow-Up Study in China / Qiu H., Wang M., Mi D. et al. // J. Nutr. Health Aging 2017, 21, 766–771.
33. Association between serum concentration of vitamin D and 1-year mortality in stroke patients / Daubail B., Jacquin A., Guilland J.-C. et al. // Cerebrovasc. Dis. – 2014, 37, 364–367.
34. Vitamin D deficiency is associated with acute ischemic stroke, C-reactive protein, and short-term outcome / Alfieri D. F., Lehmann M. F., Oliveira S. R. et al. // Metab. Brain Dis. – 2017, 32, 493–502.
35. Association between vitamin D status and cognitive impairment in acute ischemic stroke patients: a prospective cohort study / H. Chen, Y. Liu1, G. Huang et al. // Dovepress. Clinical Interventions in Aging. – 2018:13 2503–2509.
Review
For citations:
Kicherova OA, Rejhert LI, Ahmetianov MA. Risk factors for ischemic stroke. The role of vitamin D. Ural Medical Journal. 2021;20(4):93-98. (In Russ.) https://doi.org/10.52420/2071-5943-2021-20-4-93-98
Views:
1051
Email this article 